Small bowel obstruction due to metastatic colon cancer

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Systemic treatment, including monoclonal antibodies against tumor-associated targets, has increased the median survival of patients with metastatic colorectal cancer over 100% in the past few years. The prolonged life-span of these patients has led to the development of new and unusual complications that were typically not seen in the era of 5-fluorouracil and leucovorin. A multidisciplinary approach is now more crucial than ever. In this report, we will discuss a patient who presented with a metastatic lesion nearly obstructing the small bowel three years following the diagnosis of metastatic colon cancer.

Original languageEnglish (US)
Pages (from-to)S15-S18
JournalAnti-Cancer Drugs
Issue numberSPEC. ISS. 2
StatePublished - May 2009


  • Avastin
  • Multi-modality therapy

ASJC Scopus subject areas

  • Oncology
  • Pharmacology
  • Pharmacology (medical)
  • Cancer Research


Dive into the research topics of 'Small bowel obstruction due to metastatic colon cancer'. Together they form a unique fingerprint.

Cite this